61-year-old female with triple-negative breast cancer of the right

$ 29.00

4.9 (272) In stock

Evolution of synchronous female bilateral breast cancers and response to treatment

PDF) MRI as a biomarker for breast cancer diagnosis and prognosis

Federica Pediconi's research works Sapienza University of Rome, Rome (la sapienza) and other places

A Positive Outlook Amidst Triple Negative Breast Cancer – cCARE

a 61-year-old woman with multicentric left breast cancer who required a

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies - ScienceDirect

Endi KRIPA, Sapienza University of Rome, Rome, la sapienza

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer

Frontiers Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

Tumor necrosis factor superfamily co-stimulatory molecules studied in

Frontiers IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer

Endi KRIPA, Sapienza University of Rome, Rome, la sapienza

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer - ScienceDirect

Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer

Woman thriving 17 years after triple-negative breast cancer diagnosis and told she had 5 years left - Face2Face Africa